United States Autoimmune Immunomodulator Market Report 2016

November 2016 | 124 pages | ID: U6FBAADBBEBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Autoimmune Immunomodulator

Revenue, means the sales value of Autoimmune Immunomodulator

This report studies sales (consumption) of Autoimmune Immunomodulator in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• AbbVie
• Johnson & Johnson
• Amgen
• F. Hoffmann-La Roche
• Pfizer
• AstraZeneca
• Avaxia Biologics
• Biogen Idec
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Eli Lilly
• Enlivex Therapeutics
• Gilead Sciences
• Immune Pharmaceuticals
• Merck
• Mitsubishi Tanabe Pharma
• Neovacs
• Prometheus Laboratories
• Sandoz
• Sanofi
• Swedish Orphan Biovitrum
• Takeda Pharmaceuticals
• UCB

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Autoimmune Immunomodulator in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Autoimmune Immunomodulator Market Report 2016

1 AUTOIMMUNE IMMUNOMODULATOR OVERVIEW

1.1 Product Overview and Scope of Autoimmune Immunomodulator
1.2 Classification of Autoimmune Immunomodulator
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Autoimmune Immunomodulator
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Autoimmune Immunomodulator (2011-2021)
  1.4.1 United States Autoimmune Immunomodulator Sales and Growth Rate (2011-2021)
  1.4.2 United States Autoimmune Immunomodulator Revenue and Growth Rate (2011-2021)

2 UNITED STATES AUTOIMMUNE IMMUNOMODULATOR COMPETITION BY MANUFACTURERS

2.1 United States Autoimmune Immunomodulator Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Autoimmune Immunomodulator Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Autoimmune Immunomodulator Average Price by Manufactures (2015 and 2016)
2.4 Autoimmune Immunomodulator Market Competitive Situation and Trends
  2.4.1 Autoimmune Immunomodulator Market Concentration Rate
  2.4.2 Autoimmune Immunomodulator Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES AUTOIMMUNE IMMUNOMODULATOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Autoimmune Immunomodulator Sales and Market Share by Type (2011-2016)
3.2 United States Autoimmune Immunomodulator Revenue and Market Share by Type (2011-2016)
3.3 United States Autoimmune Immunomodulator Price by Type (2011-2016)
3.4 United States Autoimmune Immunomodulator Sales Growth Rate by Type (2011-2016)

4 UNITED STATES AUTOIMMUNE IMMUNOMODULATOR SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Autoimmune Immunomodulator Sales and Market Share by Application (2011-2016)
4.2 United States Autoimmune Immunomodulator Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES AUTOIMMUNE IMMUNOMODULATOR MANUFACTURERS PROFILES/ANALYSIS

5.1 AbbVie
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 AbbVie Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Johnson & Johnson
  5.2.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Johnson & Johnson Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Amgen
  5.3.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Amgen Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 F. Hoffmann-La Roche
  5.4.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 F. Hoffmann-La Roche Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 AstraZeneca
  5.6.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 AstraZeneca Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Avaxia Biologics
  5.7.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Avaxia Biologics Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Biogen Idec
  5.8.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Biogen Idec Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bristol-Myers Squibb
  5.9.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bristol-Myers Squibb Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Boehringer Ingelheim
  5.10.2 Autoimmune Immunomodulator Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Boehringer Ingelheim Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Eli Lilly
5.12 Enlivex Therapeutics
5.13 Gilead Sciences
5.14 Immune Pharmaceuticals
5.15 Merck
5.16 Mitsubishi Tanabe Pharma
5.17 Neovacs
5.18 Prometheus Laboratories
5.19 Sandoz
5.20 Sanofi
5.21 Swedish Orphan Biovitrum
5.22 Takeda Pharmaceuticals
5.23 UCB

6 AUTOIMMUNE IMMUNOMODULATOR MANUFACTURING COST ANALYSIS

6.1 Autoimmune Immunomodulator Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Autoimmune Immunomodulator

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Autoimmune Immunomodulator Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Autoimmune Immunomodulator Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES AUTOIMMUNE IMMUNOMODULATOR MARKET FORECAST (2016-2021)

10.1 United States Autoimmune Immunomodulator Sales, Revenue Forecast (2016-2021)
10.2 United States Autoimmune Immunomodulator Sales Forecast by Type (2016-2021)
10.3 United States Autoimmune Immunomodulator Sales Forecast by Application (2016-2021)
10.4 Autoimmune Immunomodulator Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Autoimmune Immunomodulator
Table Classification of Autoimmune Immunomodulator
Figure United States Sales Market Share of Autoimmune Immunomodulator by Type in 2015
Table Application of Autoimmune Immunomodulator
Figure United States Sales Market Share of Autoimmune Immunomodulator by Application in 2015
Figure United States Autoimmune Immunomodulator Sales and Growth Rate (2011-2021)
Figure United States Autoimmune Immunomodulator Revenue and Growth Rate (2011-2021)
Table United States Autoimmune Immunomodulator Sales of Key Manufacturers (2015 and 2016)
Table United States Autoimmune Immunomodulator Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Autoimmune Immunomodulator Sales Share by Manufacturers
Figure 2016 Autoimmune Immunomodulator Sales Share by Manufacturers
Table United States Autoimmune Immunomodulator Revenue by Manufacturers (2015 and 2016)
Table United States Autoimmune Immunomodulator Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Autoimmune Immunomodulator Revenue Share by Manufacturers
Table 2016 United States Autoimmune Immunomodulator Revenue Share by Manufacturers
Table United States Market Autoimmune Immunomodulator Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Autoimmune Immunomodulator Average Price of Key Manufacturers in 2015
Figure Autoimmune Immunomodulator Market Share of Top 3 Manufacturers
Figure Autoimmune Immunomodulator Market Share of Top 5 Manufacturers
Table United States Autoimmune Immunomodulator Sales by Type (2011-2016)
Table United States Autoimmune Immunomodulator Sales Share by Type (2011-2016)
Figure United States Autoimmune Immunomodulator Sales Market Share by Type in 2015
Table United States Autoimmune Immunomodulator Revenue and Market Share by Type (2011-2016)
Table United States Autoimmune Immunomodulator Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Autoimmune Immunomodulator by Type (2011-2016)
Table United States Autoimmune Immunomodulator Price by Type (2011-2016)
Figure United States Autoimmune Immunomodulator Sales Growth Rate by Type (2011-2016)
Table United States Autoimmune Immunomodulator Sales by Application (2011-2016)
Table United States Autoimmune Immunomodulator Sales Market Share by Application (2011-2016)
Figure United States Autoimmune Immunomodulator Sales Market Share by Application in 2015
Table United States Autoimmune Immunomodulator Sales Growth Rate by Application (2011-2016)
Figure United States Autoimmune Immunomodulator Sales Growth Rate by Application (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Avaxia Biologics Basic Information List
Table Avaxia Biologics Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Avaxia Biologics Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Biogen Idec Basic Information List
Table Biogen Idec Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Idec Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Enlivex Therapeutics Basic Information List
Table Enlivex Therapeutics Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enlivex Therapeutics Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Immune Pharmaceuticals Basic Information List
Table Immune Pharmaceuticals Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immune Pharmaceuticals Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Neovacs Basic Information List
Table Neovacs Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neovacs Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Prometheus Laboratories Basic Information List
Table Prometheus Laboratories Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prometheus Laboratories Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Swedish Orphan Biovitrum Basic Information List
Table Swedish Orphan Biovitrum Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Swedish Orphan Biovitrum Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceuticals Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Autoimmune Immunomodulator Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Autoimmune Immunomodulator Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Autoimmune Immunomodulator
Figure Manufacturing Process Analysis of Autoimmune Immunomodulator
Figure Autoimmune Immunomodulator Industrial Chain Analysis
Table Raw Materials Sources of Autoimmune Immunomodulator Major Manufacturers in 2015
Table Major Buyers of Autoimmune Immunomodulator
Table Distributors/Traders List
Figure United States Autoimmune Immunomodulator Production and Growth Rate Forecast (2016-2021)
Figure United States Autoimmune Immunomodulator Revenue and Growth Rate Forecast (2016-2021)
Table United States Autoimmune Immunomodulator Production Forecast by Type (2016-2021)
Table United States Autoimmune Immunomodulator Consumption Forecast by Application (2016-2021)